Baker, A. F., Dragovich, T., Tate, W. R., Ramanathan, R., Roe, D., Hsu, C., . . . Powis, G. (2006). The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.

Baker, Amanda F., Tomislav Dragovich, Wendy R. Tate, Ramesh Ramanathan, Denise Roe, Chiu-Hsieh Hsu, D. Lynn Kirkpatrick, and Garth Powis. The Antitumor Thioredoxin-1 Inhibitor PX-12 (1-methylpropyl 2-imidazolyl Disulfide) Decreases Thioredoxin-1 and VEGF Levels in Cancer Patient Plasma. 2006.

Baker, Amanda F., et al. The Antitumor Thioredoxin-1 Inhibitor PX-12 (1-methylpropyl 2-imidazolyl Disulfide) Decreases Thioredoxin-1 and VEGF Levels in Cancer Patient Plasma. 2006.